The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. Increasing demand for safe and precise drug delivery systems is a key driver expected to drive global drug infusion systems market revenue growth over the forecast period. Increasing application of drug infusion systems for chronic pain management is expected to further propel revenue growth of the global drug infusion systems market in the near future. Increasing integration of advanced equipment and up-gradation of drug infusion systems, such as flow monitoring and microflow regulators, is expected to boost global drug infusion systems market revenue growth going ahead.

The report offers an accurate forecast estimation of the Drug Infusion Market based on the recent technological and research advancements. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the Drug Infusion Market.

Click the link to get info@ https://www.emergenresearch.com/industry-report/drug-infusion-systems-market

The complete regional analysis covers:

  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Competitive Landscape:

The latest report encases an in-depth summary of the intensely competitive landscape of the global Drug Infusion Systems market, with systematic profiling of the companies operating across this industry. In this section of the report, experts have listed down the strategic initiatives undertaken by these market rivals for proposed business expansion. Additionally, it highlights the key developments and financial positions of these companies to explain the overall market scenario. The company profiles of the established and new players have also been assessed in the report through effective analytical tools like SWOT analysis.

Key players in the market include Medtronic plc, Arcomed Ag, Baxter International Inc., Insulet Corporation, Smiths Group plc, Becton, Dickinson and Company, Halyard Health, Inc., ICU Medical, Inc., Flowonix Medical Inc., and Zyno Medical LLC

Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:

Control Systems Outlook (Revenue, USD Billion; 2018–2028)

  • Open Loop System
  • Closed Loop System

Infusion Type Outlook (Revenue, USD Billion; 2018–2028)

  • Continuous Infusion
  • Intermittent Infusion
  • Patient Controlled Infusion
  • Total Parenteral Nutrition

Administration Route Outlook (Revenue, USD Billion; 2018–2028)

  • Enteral
  • Subcutaneous
  • Intravenous
  • Arterial
  • Epidural

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Pediatrics
  • Diabetes
  • Nutrition
  • Hematology
  • Analgesia
  • Chemotherapy

End-Use Outlook (Revenue, USD Billion; 2018–2028)

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.